Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis
Publication date: Available online 21 August 2017 Source:Revista Brasileira de Reumatologia (English Edition) Author(s): Sebastião Cézar Radominski, Wanderley Bernardo, Ana Patrícia de Paula, Ben-Hur Albergaria, Caio Moreira, Cesar Eduardo Fernandes, Charlles H.M. Castro, Cristiano Augusto de Freitas Zerbini, Diogo S. Domiciano, Laura M.C. Mendonça, Luciano de Melo Pompei, Mailze Campos Bezerra, Marco Antônio R. Loures, Maria Celeste Osório Wender, Marise Lazaretti-Castro, Rosa M.R. Pereira, Sergio Setsuo Maeda, Vera Lúcia Szenjenfeld, Victoria Z.C. Borba Osteoporosis is the leading cause of fra...
Source: Revista Brasileira de Reumatologia - August 22, 2017 Category: Rheumatology Source Type: research
Foundations, facts, photos and Facebook
Publication date: Available online 10 August 2017 Source:Revista Brasileira de Reumatologia (English Edition) Author(s): Marcos Renato de Assis, Francisco Airton Castro Rocha, Luís Eduardo Coelho Andrade, Roger Abramino Levy, Hilton Seda (Source: Revista Brasileira de Reumatologia)
Source: Revista Brasileira de Reumatologia - August 11, 2017 Category: Rheumatology Source Type: research
Guidelines of the Brazilian Society of Rheumatology for the diagnosis and treatment of osteoporosis in men
Publication date: Available online 8 August 2017 Source:Revista Brasileira de Reumatologia (English Edition) Author(s): Marco Antônio R. Loures, Cristiano Augusto F. Zerbini, Jaime S. Danowski, Rosa Maria R. Pereira, Caio Moreira, Ana Patrícia de Paula, Charlles Heldan M. Castro, Vera Lucia Szenjenfeld, Laura Maria C. Mendonça, Sebastião C. Radominiski, Mailze C. Bezerra, Ricardo Simões, Wanderley M. Bernardo Osteoporosis, a metabolic disease characterized by low bone mass, deterioration of the bone tissue microarchitecture and increased susceptibility to fractures, is commonly regarded as a women's hea...
Source: Revista Brasileira de Reumatologia - August 9, 2017 Category: Rheumatology Source Type: research
New guidelines for the diagnosis of fibromyalgia
Publication date: Available online 8 August 2017 Source:Revista Brasileira de Reumatologia (English Edition) Author(s): Roberto E. Heymann, Eduardo S. Paiva, José Eduardo Martinez, Milton Helfenstein, Marcelo C. Rezende, Jose Roberto Provenza, Aline Ranzolin, Marcos Renato de Assis, Daniel P. Feldman, Luiz Severiano Ribeiro, Eduardo J.R. Souza Objective To establish guidelines based on scientific evidence for the diagnosis of fibromyalgia. Material and methods Evidence collection was performed based on 9 questions regarding the diagnosis of fibromyalgia, structured using the Patient, Intervention or Indicato...
Source: Revista Brasileira de Reumatologia - August 9, 2017 Category: Rheumatology Source Type: research
Brazilian Journal of Rheumatology at 60 years
Publication date: Available online 3 August 2017 Source:Revista Brasileira de Reumatologia (English Edition) Author(s): Georges Basile Christopoulos, José Tupinambá S. Vasconcelos (Source: Revista Brasileira de Reumatologia)
Source: Revista Brasileira de Reumatologia - August 3, 2017 Category: Rheumatology Source Type: research
Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
Publication date: Available online 25 July 2017 Source:Revista Brasileira de Reumatologia (English Edition) Author(s): Alexandre Wagner Silva de Souza, Ana Luisa Calich, Henrique de Ataíde Mariz, Manuella Lima Gomes Ochtrop, Ana Beatriz Santos Bacchiega, Gilda Aparecida Ferreira, Jozelia Rêgo, Mariana Ortega Perez, Rosa Maria Rodrigues Pereira, Wanderley Marques Bernardo, Roger Abramino Levy The purpose of these recommendations is to guide the appropriate induction treatment of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) patients with active disease. The recommendations proposed by the Va...
Source: Revista Brasileira de Reumatologia - July 26, 2017 Category: Rheumatology Source Type: research
Recommendations of the Brazilian Society of Rheumatology for diagnosis and treatment of Chikungunya fever. Part 1 – Diagnosis and special situations
Publication date: Available online 25 July 2017 Source:Revista Brasileira de Reumatologia (English Edition) Author(s): Claudia Diniz Lopes Marques, Angela Luzia Branco Pinto Duarte, Aline Ranzolin, Andrea Tavares Dantas, Nara Gualberto Cavalcanti, Rafaela Silva Guimarães Gonçalves, Laurindo Ferreira da Rocha Junior, Lilian David de Azevedo Valadares, Ana Karla Guedes de Melo, Eutilia Andrade Medeiros Freire, Roberto Teixeira, Francisco Alves Bezerra Neto, Marta Maria das Chagas Medeiros, Jozélio Freire de Carvalho, Mario Sergio F. Santos, Regina Adalva de L. Couto Océa, Roger A. Levy, Carlos Augusto ...
Source: Revista Brasileira de Reumatologia - July 25, 2017 Category: Rheumatology Source Type: research
Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitora ção de Terapias Biológicas – BiobadaBrasil)
Conclusions The incidence of tuberculosis was higher among users of synthetic DMARDs and anti-TNF than among users of synthetic DMARDs and synthetic DMARDs and non-anti-TNF biologics and also occurred later, suggesting infection during treatment and no screening failure. (Source: Revista Brasileira de Reumatologia)
Source: Revista Brasileira de Reumatologia - July 22, 2017 Category: Rheumatology Source Type: research
Recommendations of the Brazilian Society of Rheumatology for the diagnosis and treatment of chikungunya fever. Part 2 – Treatment
This study is part 2 of the Recommendations of the Brazilian Society of Rheumatology (Sociedade Brasileira de Reumatologia – SBR) for the Diagnosis and Treatment of chikungunya fever and specifically addresses treatment. (Source: Revista Brasileira de Reumatologia)
Source: Revista Brasileira de Reumatologia - July 22, 2017 Category: Rheumatology Source Type: research
Association of vascular function and estimated cardiovascular risk in patients with rheumatoid arthritis
Conclusions Parameters of central haemodynamics correlate with calculated CV risk. However, both do not give exactly the same information. The question arises whether a combination of both concepts would result in an improved CV risk prediction. (Source: Revista Brasileira de Reumatologia)
Source: Revista Brasileira de Reumatologia - July 4, 2017 Category: Rheumatology Source Type: research
Measuring fatigue with multiple instruments in a Brazilian cohort of early rheumatoid arthritis patients
Conclusion Clinically relevant fatigue is a highly prevalent symptom and is mostly predicted by disability and age in the population assessed. (Source: Revista Brasileira de Reumatologia)
Source: Revista Brasileira de Reumatologia - June 27, 2017 Category: Rheumatology Source Type: research
Use of the Lower Extremity Functional Scale (LEFS-Brazil) questionnaire compared to Lequesne Algofunctional Index for definition of knee and hip osteoarthritis severity
ABSTRACT Bisphosphonates are considered first-line agents in the treatment of postmenopausal osteoporosis based on extensive experience of use, safety, and proven efficacy in reducing vertebral, non-vertebral and femur fractures. However, post-marketing reports based on the treatment of millions of patients/year over lengthy periods of time have revealed the occurrence of initially unexpected adverse effects, such as osteonecrosis of the jaw and atypical femoral fracture, leading to the restriction of treatment duration with bisphosphonates by global regulatory agencies. However, despite the association between these effec...
Source: Revista Brasileira de Reumatologia - June 26, 2017 Category: Rheumatology Source Type: research
Possible links between osteoporosis and periodontal disease
ABSTRACT Bisphosphonates are considered first-line agents in the treatment of postmenopausal osteoporosis based on extensive experience of use, safety, and proven efficacy in reducing vertebral, non-vertebral and femur fractures. However, post-marketing reports based on the treatment of millions of patients/year over lengthy periods of time have revealed the occurrence of initially unexpected adverse effects, such as osteonecrosis of the jaw and atypical femoral fracture, leading to the restriction of treatment duration with bisphosphonates by global regulatory agencies. However, despite the association between these effec...
Source: Revista Brasileira de Reumatologia - June 26, 2017 Category: Rheumatology Source Type: research
Clinical course of Behcet's disease in a patient with delayed diagnosis and radiological follow-up of the thrombi with computed tomography angiography: a five-year follow-up under immunosuppressive treatment
ABSTRACT Bisphosphonates are considered first-line agents in the treatment of postmenopausal osteoporosis based on extensive experience of use, safety, and proven efficacy in reducing vertebral, non-vertebral and femur fractures. However, post-marketing reports based on the treatment of millions of patients/year over lengthy periods of time have revealed the occurrence of initially unexpected adverse effects, such as osteonecrosis of the jaw and atypical femoral fracture, leading to the restriction of treatment duration with bisphosphonates by global regulatory agencies. However, despite the association between these effec...
Source: Revista Brasileira de Reumatologia - June 26, 2017 Category: Rheumatology Source Type: research
Treatment of postmenopausal osteoporosis: a literature-based algorithm for use in the public health care system
ABSTRACT Bisphosphonates are considered first-line agents in the treatment of postmenopausal osteoporosis based on extensive experience of use, safety, and proven efficacy in reducing vertebral, non-vertebral and femur fractures. However, post-marketing reports based on the treatment of millions of patients/year over lengthy periods of time have revealed the occurrence of initially unexpected adverse effects, such as osteonecrosis of the jaw and atypical femoral fracture, leading to the restriction of treatment duration with bisphosphonates by global regulatory agencies. However, despite the association between these effec...
Source: Revista Brasileira de Reumatologia - June 26, 2017 Category: Rheumatology Source Type: research
